AeroLeads people directory · profile
John Butera Email & Phone Number
Chief Scientific Officer and Senior Vice President of Research
at
Hager Biosciences, LLC
2 work emails found
@hagerbio.com
11 phones found area 732, 631, 516, and 610
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Scientific Officer and Senior Vice President of Research
Location
New Jersey, United States
Company size
Who is John Butera? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
John Butera is listed as Chief Scientific Officer and Senior Vice President of Research at Hager Biosciences, LLC, a with 8 employees, based in New Jersey, United States. AeroLeads shows a work email signal at hagerbio.com, phone signal with area code 732, 631, 516, 610, and a matched LinkedIn profile for John Butera.
John Butera previously worked as Chief Scientific Officer & Senior Vice President of Research at Hager Biosciences, Llc and Director, Neuroscience Medicinal Chemistry at Pfizer. John Butera holds Mini-Mba Global Biopharma Entrepreneurship from Rutgers University.
Company email context
Email format at Hager Biosciences, LLC
This section adds company-level context without repeating John Butera's masked contact details.
{first_initial}{last}@hagerbio.com
92% confidence
AeroLeads found 2 current-domain work email signals for John Butera. Compare company email patterns before reaching out.
Profile bio
About John Butera
Provide vision, strategy, and focus to drug discovery efforts in biotech environment. A scientific leader with over 25 years of diversified experience as a leading drug hunter in the pharmaceutical industry. An expert medicinal chemist with a strong history of implementing award-winning leadership strategies to successfully manage Neuroscience and Cardiovascular / Metabolic Diseases chemistry portfolios. Extensive cross-functional experience in all phases of preclinical drug discovery including (i) early hit characterization (hit to lead), (ii) structure-activity and structure-property optimization, and (iii) development-track pre-clinical leads. Comprehensive background across numerous therapeutic areas including Neuroscience, Cardiovascular & Metabolic Diseases, Muscular-skeletal Disorders, Women's Health / Fertility, and Inflammation. Demonstrated talents in organizational management, communication, vision and direction, negotiation, and change leadership. Exceptional history of strong mentorship, coaching, developing effective interdisciplinary teams, increasing efficiency and productivity, and implementing creative strategies. A past key member of the Wyeth Chemical Sciences Leadership Team, provided significant overall contributions to the Wyeth R&D Discovery Objectives. More recently, co-founded Hager Biosciences, LLC, a privately-owned biopharmaceutical company, where he applies that experience to provide scientific vision and focus to discover new medicines.Specialties: Drug Discovery and Development BiotechnologyMedicinal ChemistryLead Validation (Hit to Lead)Lead Optimization (Structure-Activity Relationship & Structure-Property Relationship)ADME/PK OptimizationOrganic SynthesisParallel SynthesisNeuroscience & Cardiovascular Pharmacology Portfolio Management
Listed skills include Drug Discovery, Medicinal Chemistry, Drug Development, Organic Synthesis, and 15 others.
Current workplace
John Butera's current company
Company context helps verify the profile and gives searchers a useful next step.
Hager Biosciences, Llc
9 roles
John Butera work experience
A career timeline built from the work history available for this profile.
Chief Scientific Officer & Senior Vice President Of Research
Current
Hager Biosciences, Llc
Privately-held / BiotechIn 2010, joined Hager Biosciences, LLC as a partner, Chief Scientific Officer, and Senior Vice President of Research. Implement and execute strategies to expand and develop the Hager Biosciences Business Model to deliver high-valued return on investment for our research partners, clients and investors.Implement operationally agile & effective drug discovery chemistry platforms such as FragPhoreTM for the pharmaceutical and biotech industries to provide licensable pre-clinical therapeutic leads and candidates and innovative medicinal chemistry solutions.
Aug 2010 - Present
Director, Neuroscience Medicinal Chemistry
Directed and managed a key portion of the chemical equity portfolio in Neuroscience and other therapeutic areas to ensure timely completion of research projects. Demonstrated expertise in the following target areas:Neurodegenerative Disease, Depression / Anxiety, Alzheimer's Disease, Neuropathic Pain, Inflammatory Pain
Oct 2009 - Mar 2010
Director Of Exploratory Medicinal Chemistry
Responsible for early med chem portfolio by heading Hit to Lead efforts in Neuroscience, Cardiovascular/Metabolic Diseases, Women's Health, and Tissue Repair at the Wyeth Princeton and Collegeville sites. Supervised and directed the research efforts of up to 21 chemists at 3 Wyeth research sites. The goal is to identify and characterize hits after an HTS. Use parallel synthesis to optimize SAR and SPR and identify viable chemotypes to push into lead optimization. Also responsible for several late stage Neuroscience Programs and Cardiovascular Programs. Led major collaborations with outside alliance partners.In addition to the Neuroscience target areas listed above, demonstrated expertise in the following target areas:Diabetes, Cardiac Arrhythmias, Urge Urinary Incontinence, Hyperlipidemia, Female Fertlity, Male Fertility, Fibroids, Fibrinolytic Impairment, Muscle Frailty, Allopecia, Osteoporosis, Vaso-motor Symptoms
Dec 2004 - Oct 2009
Associate Director
Provided line management oversight for numerous drug development programs in Neuroscience, Women's Health, Cardiovascular and Metabolic Disorders, and Muscular-Skeletal Disorders.
Jan 2000 - Dec 2004
Group Leader
Worked on CNS disorders, cardiovascular diseases, metabolic disorders, and urological diseases.
May 1995 - Jan 2000
Principal Scientist
Worked on CNS disorders, cardiovascular diseases, metabolic disorders, and urological diseases.
Sep 1991 - May 1995
Research Scientist
Wyeth-Ayerst
Worked on cardiovascular diseases, metabolic disorders, and urological diseases.
Sep 1988 - Aug 1991
Senior Scientist
Ayerst Research
Worked on aldose reductase inhibitors to treat diabetic complications.
Apr 1985 - Aug 1988
3 education records
John Butera education
Mini-Mba Global Biopharma Entrepreneurship
Rutgers University
Phd, Organic Chemistry
Stony Brook University
Bs, Chemistry
Dowling College
FAQ
Frequently asked questions about John Butera
Quick answers generated from the profile data available on this page.
What company does John Butera work for?
John Butera works for Hager Biosciences, LLC.
What is John Butera's role at Hager Biosciences, LLC?
John Butera is listed as Chief Scientific Officer and Senior Vice President of Research at Hager Biosciences, LLC.
What is John Butera's email address?
AeroLeads has found 2 work email signals at @hagerbio.com for John Butera at Hager Biosciences, LLC.
What is John Butera's phone number?
AeroLeads has found 11 phone signal(s) with area code 732, 631, 516, 610 for John Butera at Hager Biosciences, LLC.
Where is John Butera based?
John Butera is based in New Jersey, United States while working with Hager Biosciences, LLC.
What companies has John Butera worked for?
John Butera has worked for Hager Biosciences, Llc, Pfizer, Wyeth-Ayerst, and Ayerst Research.
Who are John Butera's colleagues at Hager Biosciences, LLC?
John Butera's colleagues at Hager Biosciences, LLC include Lily Joshua.
How can I contact John Butera?
You can use AeroLeads to view verified contact signals for John Butera at Hager Biosciences, LLC, including work email, phone, and LinkedIn data when available.
What schools did John Butera attend?
John Butera holds Mini-Mba Global Biopharma Entrepreneurship from Rutgers University.
What skills is John Butera known for?
John Butera is listed with skills including Drug Discovery, Medicinal Chemistry, Drug Development, Organic Synthesis, Pharmaceutical Industry, Adme, Pharmaceutical Research, and Drug Design.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial